v3.22.2.2
Business Combination - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)
9 Months Ended
May 24, 2022
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Business Acquisition [Line Items]        
Total purchase consideration, net of $46,548 cash acquired   $ 999,120,000 $ 0  
Liabilities:        
Goodwill $ 199,481,000 $ 199,481,000   $ 0
Antares Pharma, Inc        
Business Acquisition [Line Items]        
Total purchase consideration, net of $46,548 cash acquired 999,120,000      
Cash acquired 46,548,000      
Assets:        
Short-term investments 498,000      
Accounts receivable, net 82,160,000      
Inventories, net 34,379,000      
Prepaid expenses and other assets 5,241,000      
Property and equipment, net 28,661,000      
Intangibles, net 987,500,000      
Liabilities:        
Accounts Payable 7,197,000      
Accrued expenses 33,705,000      
Deferred revenue, current portion 2,509,000      
Deferred revenue, net of current portion 1,207,000      
Deferred tax liabilities, net 159,094,000      
Other long-term liabilities 135,088,000      
Net assets acquired, excluding goodwill 799,639,000      
Goodwill $ 199,500,000